You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 23, June 20, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  From the Archives Journals: Abstract and Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Head & Neck Cancer
 •Dermatology
 •Otolaryngology/ Head & Neck Surgery
 •Dermatologic Disorders
 •Neoplasms of Head & Neck
 •Melanoma
 •Prognosis/ Outcomes
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Incidence and Prognosis of Cutaneous Melanoma Involving the Head and Neck

Commentary by Carol R. Bradford, MD; Paul A. Levine, MD

JAMA. 2007;297:2628-2629.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

ARCHIVES OF OTOLARYNGOLOGY—HEAD & NECK SURGERY

Epidemiological Features and Prognostic Factors of Cutaneous Head and Neck Melanoma: A Population-Based Study

Alexander Golger, MD; Diana S. Young, BSc; Danny Ghazarian, PhD; Peter C. Neligan, MB

Objectives: To describe the epidemiological features of cutaneous head and neck melanoma (CHNM) and to identify factors associated with mortality from this disease.

Design: A population-based cohort study.

Setting: Patients treated for CHNM in Ontario between January 1, 1994, and December 31, 2002, were identified through the provincial Cancer Registry. A Cox proportional hazards regression model was used to analyze the data.

Patients: A total of 2218 patients with CHNM were identified, composing 15.8% of all melanomas in Ontario. The mean age of the cohort was 66 years (SD, 16 years); 1363 patients (61.5%) were males.

Main Outcome Measure: Patients' vital status (dead or alive).

Results: . . . [Full Text of this Article]

Author Affiliations: Department of Otolaryngology–Head and Neck Surgery, University of Michigan, Ann Arbor (Dr Bradford) and Department of Otolaryngology–Head and Neck Surgery, University of Virginia Health System, Charlottesville (Dr Levine).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.